Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Penile Neoplasms × cabazitaxel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 22 Neoplasm Metastasis 7 Neoplasms 5 Prostate Cancer Metastatic 4 Carcinoma, Transitional Cell 4 Recurrence 3 Urinary Bladder Neoplasms 2 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Carcinoma, Squamous Cell 2 Solid Cancer 1 Small Cell Lung Carcinoma 1 Penile Neoplasms 1 Ovarian Neoplasms 1 Neoplastic Cells, Circulating 1 Malignant Solid Tumor - Malignant Nervous System Neoplasm 1 Liposarcoma 1 Head and Neck Neoplasms 1 Glioblastoma 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Bone Metastatic Prostate Cancer 1 Advanced Solid Tumor 1

Interventions

Cisplatin 3 pembrolizumab 2 fludarabine phosphate 2 fludarabine 2 aldesleukin 2 aflibercept 2 Ifosfamide 2 Cyclophosphamide 2 vinflunine 1 ripretinib 1 oncogene protein E7, Human papillomavirus type 16 1 nimotuzumab 1 entinostat 1 dacomitinib 1 cabazitaxel 1 Vorinostat 1 Radiotherapy 1 Psychiatric Rehabilitation 1 Paclitaxel 1 Nivolumab 1 Neoadjuvant Therapy 1 Isotretinoin 1 Irinotecan 1 Interleukin-2 1 Interferon-alpha 1 Immunohistochemistry 1 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1 Ganciclovir 1 Fentanyl 1 Early Intervention, Educational 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03114254 2022-11-18

JAVA-P

University Hospitals Bristol and Weston NHS Foundation Trust

Phase 2 Completed

Neoplasm Metastasis, Penile Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡